67 related articles for article (PubMed ID: 19816982)
1. Targeted inhibition of the EGFR pathways enhances Zn-BC-AM PDT-induced apoptosis in well-differentiated nasopharyngeal carcinoma cells.
Koon HK; Chan PS; Wong RN; Wu ZG; Lung ML; Chang CK; Mak NK
J Cell Biochem; 2009 Dec; 108(6):1356-63. PubMed ID: 19816982
[TBL] [Abstract][Full Text] [Related]
2. Role of mitogen-activated protein kinase in Zn-BC-AM PDT-induced apoptosis in nasopharyngeal carcinoma cells.
Koon HK; Chan PS; Wu ZG; Wong RN; Lung ML; Chang CK; Mak NK
Cell Biochem Funct; 2010 Apr; 28(3):239-48. PubMed ID: 20373469
[TBL] [Abstract][Full Text] [Related]
3. Involvement of both endoplasmic reticulum and mitochondria in photokilling of nasopharyngeal carcinoma cells by the photosensitizer Zn-BC-AM.
Mak NK; Li KM; Leung WN; Wong RN; Huang DP; Lung ML; Lau YK; Chang CK
Biochem Pharmacol; 2004 Dec; 68(12):2387-96. PubMed ID: 15548385
[TBL] [Abstract][Full Text] [Related]
4. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478.
Weyergang A; Kaalhus O; Berg K
Photochem Photobiol Sci; 2008 Sep; 7(9):1032-40. PubMed ID: 18754049
[TBL] [Abstract][Full Text] [Related]
6. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Cancer Res; ; . PubMed ID: 16397255
[TBL] [Abstract][Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
